MyHealthChecked (MHC) Competitors GBX 10 -0.75 (-6.98%) As of 03:13 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock MHC vs. POLX, IHC, AVO, RUA, SUN, BELL, DEMG, NIOX, SN, and MXCTShould you be buying MyHealthChecked stock or one of its competitors? The main competitors of MyHealthChecked include Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), Belluscura (BELL), Deltex Medical Group (DEMG), NIOX Group (NIOX), Smith & Nephew (SN), and MaxCyte (MXCT). These companies are all part of the "medical devices" industry. MyHealthChecked vs. Its Competitors Polarean Imaging Inspiration Healthcare Group Advanced Oncotherapy RUA Life Sciences Surgical Innovations Group Belluscura Deltex Medical Group NIOX Group Smith & Nephew MaxCyte Polarean Imaging (LON:POLX) and MyHealthChecked (LON:MHC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment. Which has stronger valuation and earnings, POLX or MHC? MyHealthChecked has higher revenue and earnings than Polarean Imaging. MyHealthChecked is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPolarean Imaging£5.21M3.88-£69.44M-£3.89-0.35MyHealthChecked£9.43M0.55-£1.04M-£2.00-4.99 Is POLX or MHC more profitable? MyHealthChecked has a net margin of -11.06% compared to Polarean Imaging's net margin of -1,333.97%. MyHealthChecked's return on equity of -12.80% beat Polarean Imaging's return on equity.Company Net Margins Return on Equity Return on Assets Polarean Imaging-1,333.97% -86.11% -32.28% MyHealthChecked -11.06%-12.80%-8.18% Which has more volatility and risk, POLX or MHC? Polarean Imaging has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. Comparatively, MyHealthChecked has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500. Does the media refer more to POLX or MHC? In the previous week, MyHealthChecked had 1 more articles in the media than Polarean Imaging. MarketBeat recorded 1 mentions for MyHealthChecked and 0 mentions for Polarean Imaging. Polarean Imaging's average media sentiment score of 0.00 beat MyHealthChecked's score of -1.29 indicating that Polarean Imaging is being referred to more favorably in the media. Company Overall Sentiment Polarean Imaging Neutral MyHealthChecked Negative Do institutionals and insiders believe in POLX or MHC? 12.1% of Polarean Imaging shares are held by institutional investors. Comparatively, 3.1% of MyHealthChecked shares are held by institutional investors. 39.3% of Polarean Imaging shares are held by company insiders. Comparatively, 53.6% of MyHealthChecked shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryMyHealthChecked beats Polarean Imaging on 9 of the 13 factors compared between the two stocks. Get MyHealthChecked News Delivered to You Automatically Sign up to receive the latest news and ratings for MHC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MHC vs. The Competition Export to ExcelMetricMyHealthCheckedMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£5.20M£3.43B£5.54B£2.96BDividend YieldN/A2.44%5.38%5.02%P/E Ratio-4.9972.9827.38146.56Price / Sales0.55103.34422.31240,165.07Price / Cash1.7815.9936.6327.97Price / Book0.693.858.085.31Net Income-£1.04M£132.05M£3.16B£5.90B7 Day Performance-12.28%11.65%2.12%1.12%1 Month Performance-9.09%8.97%4.43%5.65%1 Year Performance5.26%14.58%35.62%82.18% MyHealthChecked Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MHCMyHealthCheckedN/AGBX 10-7.0%N/A+7.4%£5.20M£9.43M-4.9916Negative NewsEarnings ReportGap DownPOLXPolarean ImagingN/AGBX 1.36-2.6%N/A-19.5%£20.01M£5.21M-0.3528Gap DownIHCInspiration Healthcare GroupN/AGBX 23.05-1.9%N/A+30.5%£19.97M£42.87M-1.58224AVOAdvanced OncotherapyN/AN/AN/AN/A£9.50MN/A-25.003,900Gap DownRUARUA Life SciencesN/AGBX 12.50-6.5%N/A+11.7%£7.76M£4.05M-2.9148Gap DownHigh Trading VolumeSUNSurgical Innovations GroupN/AGBX 0.65-7.0%N/A+56.5%£6.07M£12.54M-21.1180News CoverageGap UpHigh Trading VolumeBELLBelluscuraN/AGBX 0.74+1.8%N/A-95.0%£1.86M£2.87M-0.0824DEMGDeltex Medical GroupN/AN/AN/AN/A£187K£1.76M-0.1537Gap UpHigh Trading VolumeNIOXNIOX Group3.0224 of 5 starsGBX 65.60+1.2%GBX 90+37.2%-0.3%£26.94B£3.53B2,707.2092SNSmith & Nephew3.6675 of 5 starsGBX 1,096.50+0.4%GBX 7,840+615.0%+14.7%£12.02B£7.08B39.4818,452High Trading VolumeMXCTMaxCyteN/AGBX 147.69-7.7%N/A-99.3%£194.96M£57.52M-5.4180Gap DownHigh Trading Volume Related Companies and Tools Related Companies Polarean Imaging Competitors Inspiration Healthcare Group Competitors Advanced Oncotherapy Competitors RUA Life Sciences Competitors Surgical Innovations Group Competitors Belluscura Competitors Deltex Medical Group Competitors NIOX Group Competitors Smith & Nephew Competitors MaxCyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:MHC) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyHealthChecked PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MyHealthChecked With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
